Key Highlights
- Lichen's indicated decline of 9.09% to USD 0.0200 coincides with a 17,500,000-unit offering at USD 0.20 and warrants for 4.72 shares each, adding dilution pressure.
- A bid price compliance date of November 23, 2026 is cited for a company indicated 8.65% lower at USD 1.32 before the open.
- An 8-for-1 consolidation on November 16, 2026 left one stock indicated at USD 9.20, down 8.64%, against a USD 22.7 million Working Capital deficit.
- Quhuo's indicated USD 3.05 sits under a 52-week low of USD 3.11, following a Nasdaq delisting determination dated March 27, 2026.
Lichen International (NASDAQ:LICN): Offering Overhang and Warrant Pressure
Lichen International is pencilled in at USD 0.0200 before the open, a retreat of 9.09% against a calculated reference point of USD 0.0220, which works out to negative USD 0.0020. No item dated November 18, 2026 is listed to account for it. Traders may still be digesting the paperwork from November 10, 2026, under which 17,500,000 units were offered at USD 0.20 apiece, with proceeds of up to USD 3.5 million and a Placement fee of USD 245,000, equal to 7%. Warrant holders could convert at no cash cost into 4.72 shares each, a route to 82,600,000 underlying shares and a Class A tally rising from 16,216,825 to 116,316,825. For Lichen International, the calculated Equity value of roughly USD 0.33 million marks it as a nano-cap exposed to dilution. Operating through subsidiaries in China, the Cayman parent had 30 prospective listing clients in its advisory pipeline at June 30, 2026, while first-half education Revenue dropped from around USD 0.76 million to zero. Dilution, minimum bid rules and regulatory exposure in the PRC are the principal hazards, so Lichen International remains a speculative name. Nano-cap risk is acute for Lichen International.
Ping An Biomedical (NASDAQ:PASW): Bid Price Deadline Draws Closer
Ping An Biomedical shows USD 1.32 in early dealings, an 8.65% step down from a calculated base of USD 1.4450, which equals a move of negative USD 0.1250. Releases or filings dated November 18, 2026 did not surface in coverage. Nasdaq's bid price deficiency notice, received November 28, 2025, is followed by a compliance date of November 23, 2026, and a reverse split remains one possible fix. For the half year to March 31, 2026, sales contracted to RMB 9.6 million from RMB 18.23 million, but profit of RMB 4.8 million owed much to RMB 11.8 million of gains outside operations, among them a RMB 6.1 million Reversal of Credit losses and a RMB 5.7 million Revaluation gain on equity. Ping An Biomedical reported RMB 35.9 million of cash and bank balances, of which RMB 29.1 million, or 81%, was tied up, alongside an equity portfolio of RMB 41.2 million. Three customers accounted for 70% of sales, and one vendor took 54% of purchases, a dependence worth noting for Ping An Biomedical. Bid compliance and share issuance are the key threats to Ping An Biomedical, and customer concentration adds to the picture.
Intercont (Cayman) (NASDAQ:NCT): Life After Two Consolidations
Intercont (Cayman) is around USD 9.20 before the open, an 8.64% fall relative to a calculated prior close of USD 10.07, a calculated loss of USD 0.87. Nothing announced on November 18, 2026 was located. A consolidation of 8 old shares into 1 took effect on November 16, 2026, shrinking Class A shares outstanding to 2,035,866 from 16,286,926, following a 25-into-1 consolidation on September 17, 2026. The Class A stake is worth roughly USD 18.73 million on a calculated basis, excluding Class B. Revenue for fiscal 2026 grew 1% to USD 25.4 million, yet the Business moved into a USD 10.7 million loss from USD 3.1 million of profit and carries a working capital Deficit of USD 22.7 million. A related counterparty, Topsheen Shipping Singapore, accounted for 67% of revenue. Management acknowledged doubt about going concern, citing Shareholder backing through October 31, 2027, and the USD 1.00 minimum bid rule still poses a challenge for Intercont (Cayman). Cash was USD 4.04 million against USD 14.53 million of total debt. Management's shareholder support for Intercont (Cayman) runs through October 31, 2027.
EpicQuest Education Group International (NASDAQ:EEIQ): Thin Cash Cushion
EpicQuest Education Group International trades near USD 3.30, a drop of 8.33% from a calculated base of USD 3.60, a calculated decline of USD 0.30. Nothing from November 18, 2026 was located. First-half fiscal 2026 sales climbed to USD 6.27 million, a 16.8% gain on USD 5.37 million, while losses deepened to USD 3.16 million from USD 0.16 million. Cash at March 31, 2026 was USD 306,941, versus USD 4.75 million at September 30, 2025. A consolidation of 1 share for every 16 became effective February 17, 2026, and a private placement on May 6, 2026 issued 150,000 shares and warrants for up to 600,000 more, producing roughly USD 0.6 million after costs. The calculated market worth is around USD 5.43 million, so EpicQuest Education Group International faces nano-cap risk. Equity stood at USD 7.25 million compared with USD 8.81 million a year before, and a first US campus is aimed at Spring 2027. EpicQuest Education Group International also reported lower stockholders' equity year on year. Cash of USD 306,941 leaves EpicQuest Education Group International with thin reserves.
Quhuo (NASDAQ:QH): Delisting Determination Shapes the Backdrop
Quhuo sits at USD 3.05 before the open, down 5.86% against a calculated prior close of USD 3.2398, a calculated shift of negative USD 0.1898. No dated announcement from November 18, 2026 was located. A Nasdaq staff determination to delist arrived March 27, 2026 over a bid price below the required level, and the firm made that public on April 2, 2026. Quhuo also announced an ADS ratio revision on April 24, 2026, an AI data alliance with Wons on April 27, 2026, and a registration statement on May 11, 2026. The indicated figure lies beneath the 52-week low of USD 3.11, while the high was USD 7.10. Revenue over the Trailing Twelve Months came to 361.13 million yuan, shrinking 17.1%, and the net deficit was 21.37 million yuan. With roughly 2.75 million shares, the calculated Market Value is about USD 8.39 million, so thin trading and dilution from registered offerings are the main issues for Quhuo. Quhuo is priced below its 52-week low.
Where Things Stand
Lichen International leads the declines at 9.09%, with a calculated equity value near USD 0.33 million. Ping An Biomedical has slipped 8.65% as its bid compliance deadline of November 23, 2026 approaches. Intercont (Cayman) is lower by 8.64% following its 8-for-1 consolidation. EpicQuest Education Group International gave up 8.33% and holds USD 306,941 in cash. Quhuo shed 5.86%. Nothing dated November 18 explains the group, and early quotes can reverse once regular trading begins, so this is not Investment advice.






Please wait processing your request...